DK0914078T3 - Anvendelse af L-lysin til behandling af hårtab - Google Patents

Anvendelse af L-lysin til behandling af hårtab

Info

Publication number
DK0914078T3
DK0914078T3 DK97925169T DK97925169T DK0914078T3 DK 0914078 T3 DK0914078 T3 DK 0914078T3 DK 97925169 T DK97925169 T DK 97925169T DK 97925169 T DK97925169 T DK 97925169T DK 0914078 T3 DK0914078 T3 DK 0914078T3
Authority
DK
Denmark
Prior art keywords
pct
lysine
treatment
hair loss
sec
Prior art date
Application number
DK97925169T
Other languages
English (en)
Inventor
David Hugh Rushton
Original Assignee
Bio Scient Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Scient Ltd filed Critical Bio Scient Ltd
Application granted granted Critical
Publication of DK0914078T3 publication Critical patent/DK0914078T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DK97925169T 1996-06-10 1997-06-06 Anvendelse af L-lysin til behandling af hårtab DK0914078T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9612108A GB2314019B (en) 1996-06-10 1996-06-10 The use of L-Lysine in the treatment of hair loss
PCT/GB1997/001542 WO1997047276A1 (en) 1996-06-10 1997-06-06 The use of l-lysine in the treatment of hair loss

Publications (1)

Publication Number Publication Date
DK0914078T3 true DK0914078T3 (da) 2003-02-17

Family

ID=10795046

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97925169T DK0914078T3 (da) 1996-06-10 1997-06-06 Anvendelse af L-lysin til behandling af hårtab

Country Status (13)

Country Link
US (1) US6136860A (da)
EP (1) EP0914078B1 (da)
JP (1) JP2000511876A (da)
AT (1) ATE226058T1 (da)
AU (1) AU721751B2 (da)
CA (1) CA2257607C (da)
DE (1) DE69716434T2 (da)
DK (1) DK0914078T3 (da)
ES (1) ES2185942T3 (da)
GB (1) GB2314019B (da)
NZ (1) NZ333108A (da)
PT (1) PT914078E (da)
WO (1) WO1997047276A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037071A1 (en) * 1998-12-21 2000-06-29 Aps Kbus 8 Nr. 4788 Topical treatment of skin disease
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US6596266B2 (en) 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
WO2002094256A1 (en) * 2001-05-23 2002-11-28 Debatosh Datta Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
ITMI20011732A1 (it) * 2001-08-07 2003-02-07 Indena Spa Composizioni farmaceutiche e/o cosmetiche orali per il trattamento e la prevenzione di disturbi del cuoio capelluto
KR100873664B1 (ko) 2004-04-28 2008-12-11 코스모세키유 가부시키가이샤 육모제
US7705010B2 (en) * 2005-02-22 2010-04-27 Cedars-Sinai Medical Center Use of minoxidil sulfate as an anti-tumor drug
WO2007142349A1 (ja) * 2006-06-08 2007-12-13 Ajinomoto Co., Inc. 育毛用組成物
DE102008012988A1 (de) * 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
CN115998740A (zh) 2014-10-29 2023-04-25 萨姆森临床私人有限公司 毛发过度脱落的检测和治疗
EP3175837A1 (en) 2015-12-01 2017-06-07 Noxell Corporation Method for treating hair
ES2725009T3 (es) * 2016-03-04 2019-09-18 Laboratorio Reig Jofre S A Comprimidos con un alto contenido de principios activos útiles para el tratamiento de la pérdida de cabello o la estimulación de su crecimiento
AU2018250398B2 (en) * 2017-07-12 2019-02-28 Samson Clinical Pty Ltd Promoting hair growth and treatment of hair loss or excessive hair shedding

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB720561A (en) * 1952-04-17 1954-12-22 Frederick Victor Wells Improvements in preparations for application to the hair and scalp
LU54223A1 (da) * 1967-08-01 1969-03-24
BE789856A (fr) * 1971-10-13 1973-02-01 Tixier Georges Medicament a base de derives de la lysine susceptibles de stimuler differents metabolismes, en particulier la genese des leucocytes
DE3118882C2 (de) * 1981-05-13 1985-11-14 Rudolf V. Dr.rer.nat Dipl.-Chem. 5024 Pulheim Noronha Mittel gegen Haarausfall und zur Förderung des Haarwuchs
JPS60142908A (ja) * 1983-12-29 1985-07-29 Kanebo Ltd 養毛化粧料
US5470876A (en) * 1985-07-18 1995-11-28 Proctor; Peter H. Topical sod for treating hair loss
AU6131686A (en) * 1985-07-18 1987-02-10 Proctor, P.H. Topical composition and method for stimulating hair growth
DE68917946T2 (de) * 1988-01-29 1995-01-05 Peter H Proctor Haarwachstumanregung mit Nitroxyd und anderen Radikalen.
FR2609393A1 (fr) * 1988-02-23 1988-07-15 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques comprenant une substance azotee, notamment aminoacides, oligo- ou polypeptides, proteines, et leurs derives, et composition pharmaceutique ou cosmetique ainsi preparee.
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
US5133958A (en) * 1989-04-20 1992-07-28 Erwin Stuckler Agent for nail, skin and hair care
US5122369A (en) * 1990-03-30 1992-06-16 Harmony Health Products, Inc. Nutrient composition for preventing hair loss
FR2669224B1 (fr) * 1990-11-15 1995-04-28 Marcel Contier Compositions capillaires, destinees notamment a la neutralisation de l'acide lactique du cuir chevelu et methode de traitement cosmetique du cuir chevelu.
GB9210768D0 (en) * 1992-05-20 1992-07-08 Unilever Plc Cosmetic composition
DE19520662A1 (de) * 1995-06-07 1996-12-12 Beiersdorf Ag Mittel zur Behandlung von Kopfschuppen und zur Behandlung der Haare

Also Published As

Publication number Publication date
DE69716434T2 (de) 2003-06-18
ES2185942T3 (es) 2003-05-01
GB2314019B (en) 2000-03-15
CA2257607C (en) 2010-11-02
CA2257607A1 (en) 1997-12-18
EP0914078A1 (en) 1999-05-12
EP0914078B1 (en) 2002-10-16
AU3040497A (en) 1998-01-07
DE69716434D1 (de) 2002-11-21
PT914078E (pt) 2003-02-28
GB9612108D0 (en) 1996-08-14
GB2314019A (en) 1997-12-17
JP2000511876A (ja) 2000-09-12
GB2314019A8 (en) 1998-03-30
AU721751B2 (en) 2000-07-13
ATE226058T1 (de) 2002-11-15
WO1997047276A1 (en) 1997-12-18
US6136860A (en) 2000-10-24
NZ333108A (en) 2000-05-26
HK1019552A1 (en) 2000-02-18

Similar Documents

Publication Publication Date Title
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DK0914078T3 (da) Anvendelse af L-lysin til behandling af hårtab
NO975716D0 (no) Imidazolforbindelser
ES2102813T3 (es) Composiciones farmaceuticas y dermocosmeticas que contienen calostro equino.
PT935465E (pt) Compostos novos de imidazole substituido
TR200202323T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavß6 antagonistleriyle tedavisi
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
FR2719768B1 (fr) Utilisation d'extraits de bactéries filamenteuses comme agents cosmétiques contre le vieillissement cutané.
ES2148550T3 (es) Composicion de tinte para el cabello.
ATE49115T1 (de) Haarbehandlungsmittel.
DK0684036T3 (da) Anvendelse af polyorganosiloxaner i midler til affarvning af menneskehår
DK0678013T3 (da) Præparater til behandling af hår
PH31673A (en) Method of preventing and treating chemotherapy-induced alopecia.
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DE59510131D1 (de) Imidazopyridin-azolidinone
ATE145191T1 (de) Azofarbstoffe enthaltende molekularsiebe
DK0663832T3 (da) Anvendelse af 4'-iod-4'-deoxydoxorubicin til behandling af amyloidose
HUP9900007A2 (hu) Készítmény baromfialom kezelésére
ES2136615T3 (es) Nuevos inhibidores de glucohidrolasa utiles como agentes antidiabeticos, antiviricos y antimetastasicos.
FI960026A0 (fi) Värejä, joissa on tetra-aminopyrimidiiniä ja suoravärjäysaineita
GR3023486T3 (en) Use of hydroxynaphthalenes in colouring agents
ITFI960104A0 (it) Macchina per trattamenti di concia e simili
NO933730D0 (no) Laas for paahengsmotorer, aarer og annet
BR7301078U (pt) Kit para isolamento de microbactérias, em laminocultivo